Private Eye

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Off-market insider buying at CBD Global Sciences (C:CBDN)

Updated Thursday Jan 13, 2022 02:15 AM EDT

Alex McAulay, a Senior Officer, acquired 2,086,800 Common Shares on an indirect ownership basis for registered holder ACM Management Inc. at a price of $0.158 through a private transaction on December 31st, 2021. This represents a $328,671 investment into the company's shares and an account share holdings change of greater than 100%.

CBD Global Sciences is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

CBD Global Sciences Inc. is a Canada-based cannabidiol (CBD) producer. The Company is engaged in the business of producing and selling industrial hemp derived CBD infused consumable and topical products, including but not limited to CBD oil tincture drops, CBD hydration beverages, and CBD topicals. It markets and sells its own brand of CBD oil and byproducts under the Aethics and CannaOil brands (Products), which includes CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, hydration products and confectionary products. Its hemp-derived CBD extracts are sold through distributors, brick and mortar retailers and online. The Company, through its wholly owned subsidiaries, Global Sciences Holdings, Resinosa LLC and Legacy Distribution Group, is delivering CBD products both in a retail and e-commerce formats. Its subsidiaries include Strasburg Pharms, LLC, Global NV Corp., CannaOil, Inc., SMBT, LLC, Global Sciences IP, LLC and Energy Unleased LLC, among others.

INK Edge Outlook

CONDITIONS:
Latest
6 months ago
1 year ago
Overall
N/A
N/A
N/A
The INK Edge Outlook is a quantitative process that ranks a stock based on our V.I.P. criteria.
View outlooks on all Canadian listed stocks at inkresearch.com.
Two-week free trial for first time users.
Go to CBD Global Sciences Inc. (CBDN)'s company page

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Comment On!

No Comments

Twitter

Search (past week) for $CBDN.CA

  • No tweets found

Stocktwits

CBD Global Sciences Inc.

  • Symbol not found.